Page last updated: 2024-10-24

cornified envelope

Definition

Target type: cellularcomponent

A type of plasma membrane that has been modified through addition of distinct intracellular and extracellular components, including ceramide, found in cornifying epithelial cells (corneocytes). [GOC:add, PMID:11112355, PMID:11590230, PMID:15803139]

The cornified envelope (CE) is a specialized, highly cross-linked protein structure that forms the outermost layer of the stratum corneum in vertebrate skin. It provides a barrier against environmental insults and contributes to the skin's mechanical strength. The cellular component of the CE is a complex mixture of proteins, primarily cytokeratins, cross-linked by transglutaminase enzymes. The major cytokeratins involved in CE formation are cytokeratins 1 and 10, which are expressed in the upper layers of the epidermis and are specifically upregulated in differentiating keratinocytes. These cytokeratins are synthesized as precursors, which are then processed and assembled into intermediate filaments. During the terminal differentiation of keratinocytes, the intermediate filaments undergo extensive cross-linking through the action of transglutaminases, primarily transglutaminase 1 (TG1). TG1 is a calcium-dependent enzyme that catalyzes the formation of isopeptide bonds between specific lysine and glutamine residues in the cytokeratins, leading to the formation of a rigid, insoluble network. In addition to cytokeratins, other proteins have been found to be incorporated into the CE, including loricrin, involucrin, and small proline-rich proteins (SPRRs). These proteins contribute to the structural integrity and barrier function of the CE. The formation of the CE is a tightly regulated process that is essential for skin barrier function. Defects in CE formation can lead to skin disorders, such as ichthyosis and epidermolytic hyperkeratosis. The CE is a unique and complex cellular component that plays a critical role in skin biology.'
"

Proteins (6)

ProteinDefinitionTaxonomy
Kallikrein-6A kallikrein-6 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92876]Homo sapiens (human)
Kallikrein-7A kallikrein-7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49862]Homo sapiens (human)
Caspase-14A caspase-14 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P31944]Homo sapiens (human)
Calpain-1 catalytic subunitA calpain-1 catalytic subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07384]Homo sapiens (human)
Annexin A2An annexin A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07355]Homo sapiens (human)
Heat shock protein beta-1A heat shock protein beta-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04792]Homo sapiens (human)

Compounds (29)

CompoundDefinitionClassesRoles
isoquinoline-1,3,4-trioneisoquinoline-1,3,4-trione: structure in first source
aloxistatinaloxistatin : An L-leucine derivative that is the amide obtained by formal condensation of the carboxy group of (2S,3S)-3-(ethoxycarbonyl)oxirane-2-carboxylic acid with the amino group of N-(3-methylbutyl)-L-leucinamide.

aloxistatin: a membrane-permeable cysteine protease inhibitor
epoxide;
ethyl ester;
L-leucine derivative;
monocarboxylic acid amide
anticoronaviral agent;
cathepsin B inhibitor
carbobenzoxyvalylphenylalanine aldehydeZ-Val-Phe-H : A dipeptide resulting from the formal condensation of the carboxy group of N-benzyloxycarbonyl-L-valine with the amino group of L-phenylalanine aldehyde. It is a potent cell-permeable inhibitor of calpain I and II, and is also a gamma-secretase inhibitor.aldehyde;
carbamate ester;
dipeptide
antileishmanial agent;
apoptosis inhibitor;
EC 3.4.22.52 (calpain-1) inhibitor;
EC 3.4.22.53 (calpain-2) inhibitor;
EC 3.4.23.46 (memapsin 2) inhibitor
calpeptinamino acid amide
n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamineN-(N-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine: inhibits calcium-activated neutral protease; see also record for E-64; RN given refers to (2-S-(2alpha,3beta)(R*)-isomer)leucine derivative
e 64E 64: cysteine protease inhibitor of microbial origin, which inhibits cathepsin B (EC 3.4.22.1) and cathepsin L (EC 3.4.22.-)dicarboxylic acid monoamide;
epoxy monocarboxylic acid;
guanidines;
L-leucine derivative;
zwitterion
antimalarial;
antiparasitic agent;
protease inhibitor
birb 796aromatic ether;
morpholines;
naphthalenes;
pyrazoles;
ureas
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
immunomodulator
acetylleucyl-leucyl-norleucinalacetylleucyl-leucyl-norleucinal : A tripeptide composed of N-acetylleucyl, leucyl and norleucinal residues joined in sequence.

acetylleucyl-leucyl-norleucinal: a proteasome inhibitor
aldehyde;
tripeptide
cysteine protease inhibitor
N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamideanilide
benzyloxycarbonyl-phe-ala-fluormethylketonecathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1).
3-deoxysappanchalcone2'-O-methylisoliquiritigenin : A member of the class of chalcones that is isoliquiritigenin in which one of the hydroxy groups at position 2' is replaced by a methoxy group.

3-deoxysappanchalcone: Anti-allergic from the roots and heartwood of Caesalpinia sappan; structure in first source
chalcones;
monomethoxybenzene;
phenols
metabolite
paepalantinepaepalantine: an isocoumarin from Paepalanthus vellozioides; structure given in first source
gabexate methanesulfonatebenzoate ester;
guanidines;
methanesulfonate salt
snj-1945((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester: calpain inhibitor
phenylalanyl-valineVal-Phe : A dipeptide formed from L-valine and L-phenylalanine residues.dipeptidemetabolite
ca 074
a-705253A-705253: structure in first source
sb 242235SB 242235: p38 MAP kinase antagonist
sja 6017N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal: structure in first source
rpr 120844
phevalinphevalin : A member of the class of pyrazinones that is pyrazin-2(1H)-one substituted by an isopropyl and benzyl groups at position 3 and 6, respectively. It is a natural product found in Staphylococcus aureus that inhibits calpain in a casein hydrolysis assay (IC50 = 1.3 muM), contributes to S. aureus infection in mice, and alters human keratinocyte gene expression.

phevalin: isolated from a Streptomyces sp.; structure given in first source
benzenes;
pyrazinone
bacterial metabolite;
calpain inhibitor
calpain inhibitor iiicalpain inhibitor III: potential anticataract drug
PF-00835231PF-00835231 : A primary alcohol resulting from the cleavage of the phosphate group of the prodrug PF-07304814. It is an inhibitor of SARS-CoV-1 and -2 main protease (3CLpro) and exhibits potent in vitro antiviral activity.aromatic ether;
indolecarboxamide;
L-leucine derivative;
primary alcohol;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
drug metabolite;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamideN-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamide : A dicarboxylic acid diamide obtained by condensation of the 3- and 4'-carboxy groups of 6-methyl[1,1'-biphenyl]-3,4'-dicarboxylic acid with cyclpropylamine and cyclpropylmethylamine respectively.benzamides;
biphenyls;
cyclopropanes;
dicarboxylic acid diamide
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source
skepinone-lskepinone-L: a dibenzosuberone-type p38 MAPK inhibitor; structure in first source
nsc751382
MK-8353MK-8353 : A member of the class of indazoles that is 1H-indazole substituted by a 6-(propan-2-yloxy)pyridin-3-yl group at position 3 and by a {[(3S)-3-(methylsulfanyl)-1-(2-{4-[4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]-3,6-dihydropyridin-1(2H)-yl}-2-oxoethyl)pyrrolidin-3-yl]carbonyl}amino group at position 5. It is a potent and selective inhibitor of ERK1 and ERK2 in vitro (IC50 values of 23.0 nM and 8.8 nM, respectively). The drug is being developed by Merck Sharp & Dohme and is currently in clinical development for the treatment of advanced/metastatic solid tumors.

MK-8353: ERK inhibitor used in oncology
aromatic ether;
dihydropyridine;
indazoles;
methyl sulfide;
N-alkylpyrrolidine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
triazoles
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamideN-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-cyclohexyl-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.53 muM).aldehyde;
indolecarboxamide;
oligopeptide;
pyrrolidin-2-ones;
secondary carboxamide
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor